To include your compound in the COVID-19 Resource Center, submit it here.

Marizev omarigliptin regulatory update

Merck said it will not submit an NDA to FDA

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE